For help on how to get the results you want, see our search tips.
1939 results
Medicine
Orphan designations Remove Orphan designations filter
Summaries of opinion Remove Summaries of opinion filter
Orphan designation status
Positive Remove Positive filter
-
List item
Orphan designation: 7-Beta-hydroxy cholesteryl-3-beta-oleate for: Treatment of glioma (updated)
Date of designation: 17/12/2010, Positive, Last updated: 22/09/2023 -
List item
Orphan designation: (S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one for: Treatment of sickle cell disease (updated)
Date of designation: 19/10/2020, Positive, Last updated: 22/09/2023 -
List item
Orphan designation: Talquetamab for: Treatment of multiple myeloma (updated)
Date of designation: 20/08/2021, Positive, Last updated: 21/09/2023 -
List item
Orphan designation: Celecoxib, Ciprofloxacin for: Treatment of amyotrophic lateral sclerosis (updated)
Date of designation: 06/01/2021, Positive, Last updated: 19/09/2023 -
List item
Orphan designation: 3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid for: Treatment of non-infectious uveitis (updated)
Date of designation: 19/06/2015, Positive, Last updated: 18/09/2023 -
List item
Orphan designation: N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-(morpholin-4-yl)ethoxy) imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea di-hydrochloride salt for: Treatment of acute myeloid leukaemia (updated)
Date of designation: 23/03/2009, Positive, Last updated: 15/09/2023 -
List item
Orphan designation: Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with N-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) for: Treatment of hypoparathyroidism (updated)
Date of designation: 19/10/2020, Positive, Last updated: 15/09/2023 -
List item
Orphan designation: Dabrafenib mesylate for: Treatment of glioma (updated)
Date of designation: 09/12/2020, Positive, Last updated: 15/09/2023 -
List item
Orphan designation: Asunercept for: Treatment of myelodysplastic syndromes (updated)
Date of designation: 23/08/2017, Positive, Last updated: 15/09/2023 -
List item
Orphan designation: Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule for: Treatment of glioma (updated)
Date of designation: 28/01/2010, Positive, Last updated: 15/09/2023 -
List item
Orphan designation: Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule for: Prevention of graft-versus-host disease (updated)
Date of designation: 31/10/2006, Positive, Last updated: 15/09/2023 -
List item
Orphan designation: 2-[6-(6,7-Dimethoxyquinolin-3-yl)pyridin-3-yl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide (zeteletinib) for: Treatment of medullary thyroid carcinoma (updated)
Date of designation: 19/02/2021, Positive, Last updated: 13/09/2023 -
List item
Orphan designation: Entinostat for: Treatment of Hodgkin's lymphoma (updated)
Date of designation: 10/06/2010, Positive, Last updated: 13/09/2023 -
List item
Orphan designation: Mixture of seven synthetic fragments consisting of p21 RAS peptides for: Treatment of pancreatic cancer (updated)
Date of designation: 05/08/2011, Positive, Last updated: 13/09/2023 -
List item
Orphan designation: Lentiviral vector carrying the Fanconi anaemia-A (FANCA) gene for: Treatment of Fanconi anaemia type A (updated)
Date of designation: 17/12/2010, Positive, Last updated: 11/09/2023 -
List item
Orphan designation: 2',3',5'-Tri-O-acetyluridine for: Treatment of 5-fluorouracil overdose (updated)
Date of designation: 15/05/2009, Positive, Last updated: 11/09/2023 -
List item
Orphan designation: 4-Amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride (ronopterin) for: Treatment of moderate and severe traumatic brain injury
Date of designation: 28/08/2006, Positive, Last updated: 11/08/2023 -
List item
Orphan designation: Recombinant human factor IX protein modified with three point mutations (dalcinonacog alfa) for: Treatment of haemophilia B
Date of designation: 20/06/2017, Positive, Last updated: 03/08/2023 -
List item
Orphan designation: Marzeptacog alfa (activated) for: Treatment of haemophilia B
Date of designation: 01/04/2019, Positive, Last updated: 03/08/2023 -
List item
Orphan designation: Ganaxolone for: Treatment of CDKL5 deficiency disorder
Date of designation: 13/11/2019, Positive, Last updated: 31/07/2023 -
List item
Orphan designation: Mavorixafor for: Treatment of WHIM syndrome
Date of designation: 25/07/2019, Positive, Last updated: 26/07/2023 -
List item
Orphan designation: Iodine (124I) evuzamitide for: Diagnosis of ATTR amyloidosis
Date of designation: 09/12/2022, Positive, Last updated: 25/07/2023 -
List item
Orphan designation: Iodine (124I) evuzamitide for: Diagnosis of AL amyloidosis
Date of designation: 11/11/2022, Positive, Last updated: 25/07/2023 -
List item
Orphan designation: Dersimelagon for: Treatment of erythropoietic protoporphyria
Date of designation: 16/03/2022, Positive, Last updated: 21/07/2023 -
List item
Orphan designation: edaravone for: Treatment of amyotrophic lateral sclerosis
Date of designation: 19/06/2015, Positive, Last updated: 21/07/2023